Clinical Research
Log in
Clinical Research Details
Back to List
Descriptive Information
Title
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Investigator Name
Bassem Yamout
Email
yamoutba@gmail.com
Protocol Id
109MS202
Status
Completed- Has Results
Study Type
Clinical Research
-
Clinical Trials (phase 0, 1,2 3 & 4)
Phase
Phase 2
Looking for Med Students Volunteers
No
Collaborators
Samia Khoury
Nabil El Ayoubi
Stephanie Ghassan
Ali Taha
Lily Helal
Marianne Said
Maya Zeineddine
Lina Abdul-Latif Malaeb
Tony Assaad
Ghassan Sleiman
Lara Al-Hakim
Sponsors
Biogen
Conditions and Keywords
Conditions
Multiple Sclerosis
Keywords
Multiple Sclerosis,Dimethyl Fumarate
Study Design
Primary Purpose
Treatment
Time Perspective
Prospective
Masking
Open Label
Intervention Model
Single Group
Allocation
N/A: Single arm study
Observational Study Model
Case-Only
Eligibility and IRB
Gender
Both
Age Limits
Min:
10
Max:
17
IRB Approval
Yes
Healthy Volunteer
No
Study Description
Population Description
Sampling Method
Inclusion Criteria
Exclusion Criteria
Back to List
